Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Shu Guang Yang"'
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71930 (2013)
OBJECTIVE: The prognostic significance of survivin for the survival of patients with gastric cancer remains controversial. Thus, the objective of this study was to conduct a systematic review of the literature evaluating survivin expression in gastri
Externí odkaz:
https://doaj.org/article/3444f38a8aaa4c0088f89991273e03a2
Autor:
Gang-Bin Tang, Ting-Wei Mi, Man-Lian Sun, Ya-Jie Xu, Shu-Guang Yang, Hong-Zhen Du, Saijilafu, Zhao-Qian Teng, Jun Gao, Chang-Mei Liu
Publikováno v:
IBRO Reports, Vol 9, Iss , Pp 138-146 (2020)
5-hydroxytryptamine receptor 5B (5-HT5B) is a gene coding for a G protein-coupled receptor (GPCR) that plays key roles in several neurodevelopmental disorders. Our previous study showed that disruption of 5-HT5B induced by lysine (K)-specific demethy
Externí odkaz:
https://doaj.org/article/6a8a5c290771421b8c062027f8d81ad3
Publikováno v:
Forests, Vol 13, Iss 4, p 531 (2022)
Myelocytomatosis (MYC) transcription factors play a core regulator in the jasmonic acid signaling pathway, which regulates the secondary laticifer differentiation and rubber biosynthesis in rubber tree (Hevea brasiliensis). However, there are current
Externí odkaz:
https://doaj.org/article/a3faeb47693b41fa91222195ed113c8f
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 14 (2020)
Mammalian retinal ganglion cells (RGCs) in the central nervous system (CNS) often die after optic nerve injury and surviving RGCs fail to regenerate their axons, eventually resulting in irreversible vision loss. Manipulation of a diverse group of gen
Externí odkaz:
https://doaj.org/article/1f06d9d4f6a04b2a8802aafbb2cd5fe5
Autor:
Xue-Qi Peng, Shang-Kun Dai, Chang-Ping Li, Pei-Pei Liu, Zhi-Meng Wang, Hong-Zhen Du, Zhao-Qian Teng, Shu-Guang Yang, Chang-Mei Liu
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 14 (2020)
Trauma or neurodegenerative diseases trigger the retrograde death of retinal ganglion cells (RGCs), causing an irreversible functional loss. AT-rich interaction domain 1A (ARID1A), a subunit of the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin r
Externí odkaz:
https://doaj.org/article/239fde24534e44418fdf42e45f582e59
Autor:
Xue-Wei Wang, Shu-Guang Yang, Chi Zhang, Ming-Wen Hu, Jiang Qian, Jin-Jin Ma, Yingchi Zhang, Bin-Bin Yang, Yi-Lan Weng, Guo-Li Ming, Anish R. Kosanam, Saijilafu, Feng-Quan Zhou
Publikováno v:
Cell Reports, Vol 31, Iss 3, Pp - (2020)
Summary: In addition to altered gene expression, pathological cytoskeletal dynamics in the axon are another key intrinsic barrier for axon regeneration in the central nervous system (CNS). Here, we show that knocking out myosin IIA and IIB (myosin II
Externí odkaz:
https://doaj.org/article/bb0c04d931504ca59145aa66a31b03c9
Autor:
Xue-Wei Wang1,2, Shu-Guang Yang1, Ming-Wen Hu3, Rui-Ying Wang1, Chi Zhang1,4, Kosanam, Anish R.1, Ochuba, Arinze J.1, Jing-Jing Jiang1, Ximei Luo3, Yun Guan4, Jiang Qian3, Chang-Mei Liu5, Feng-Quan Zhou1,6
Publikováno v:
Journal of Clinical Investigation. 2/1/2024, Vol. 134 Issue 3, preceding p1-19. 20p.
Publikováno v:
Chinese Journal of Polymer Science. 40:556-566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88b251aff22b6eed87661b726643963b
https://doi.org/10.1007/s10118-022-2722-4
https://doi.org/10.1007/s10118-022-2722-4
Publikováno v:
Frontiers in pharmacology. 13
Background and objective: Idiopathic pulmonary fibrosis (IPF) is a critical disease, with limited treatments available. Clinical practices show that traditional Chinese medicine (TCM) has certain efficacy. This study was preliminarily to evaluate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13798abedb1dde61efc3276255738e2f
https://pubmed.ncbi.nlm.nih.gov/36386223
https://pubmed.ncbi.nlm.nih.gov/36386223
Autor:
Miao Zhou, Jian-sheng Li, Shu-guang Yang, Yong Meng, Wei Zhang, Chengjun Ban, Weixian Luo, Xuechao Lu, Lei Wu, Xue-qing Yu, Jihong Feng, Yong He, Linmin Zhao, Yang Xie
Publikováno v:
Trials. 23
Background and rationale Idiopathic pulmonary fibrosis is a critical disease with a poor prognosis. Although different studies have been conducted for the treatment of idiopathic pulmonary fibrosis, limited treatments are available. Jin-shui Huan-xia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8981ea13d5acc9fd0c9e9ffa5d6b00
https://doi.org/10.1186/s13063-022-06684-0
https://doi.org/10.1186/s13063-022-06684-0